Concepedia

Dejan Maglic

DM

Statistics

Publications

15

Citations

1.5K

H-Index

15

Active since

2009

Affiliations

Wake Forest University(Current)

Harvard Stem Cell Institute

D. E. Shaw Research

Boston Children's Hospital

Harvard University

Dejan Maglic is an author at Wake Forest University specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2009–2024

15

Publications

15

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

Yumeng Wang, Xiaoyan Xu, Dejan Maglic et al. · Cell Reports · 2018 · 517 citations · Full text

, , +17

Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer

Priscilla Cheung, Jordi Xiol, Michael T. Dill et al. · Cell stem cell · 2020 · 189 citations · Full text

, , +14

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance

Pankaj Taneja, Dejan Maglic, Fumitake Kai et al. · Clinical Medicine Insights Oncology · 2010 · 156 citations · Full text

, , +15

RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across <i>FGFR2</i> Alterations and Resistance Mutations

Vivek Subbiah, Vaibhav Sahai, Dejan Maglic et al. · Cancer Discovery · 2023 · 119 citations · Full text

, , +16

YAP‐TEAD signaling promotes basal cell carcinoma development via a c‐JUN/AP1 axis

Dejan Maglic, Karin Schlegelmilch, Antonella F. M. Dost et al. · The EMBO Journal · 2018 · 78 citations · Full text

, , +17

1–5 of 15